Results 81 to 90 of about 125,761 (305)
Yousef AA, Mohamed FY, Boraey NF, et al. J Inflamm Res. 2020;13:1103— 1111. The authors have advised the affiliation list on page 1103is incorrect.
Yousef AA +20 more
doaj
Structural modification of DNA--a therapeutic option in SLE?
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organs, with glomerulonephritis representing a frequent and serious manifestation.
Steffen Frese +3 more
core +1 more source
Objective Hydroxychloroquine (HCQ) is the cornerstone of systemic lupus erythematosus (SLE) management with benefits extending beyond SLE control, including protection against atherosclerotic cardiovascular disease (ASCVD). Although HCQ blood levels reflect recent exposure and long‐term intake reflects medication adherence, the impact of longitudinal ...
Shivani Garg +5 more
wiley +1 more source
Background:The autoimmune disease systemic lupus erythematosus (SLE) can cause multisystemic tissue damage because of the interaction between the autoantibodies and self-antigens.
Hawraa S. Al-Mozani, Sajidah F. Hasan
doaj +1 more source
Objectives:Systemic lupus erythematosus (SLE) affects Black people two to three times more frequently than non-Black people and is associated with higher morbidity and mortality.
core
Belimumab : a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis [PDF]
Objectives: To undertake a systematic review and meta-analysis to investigate clinical effectiveness of belimumab for patients with systemic lupus erythematosus (SLE) and antinuclear and/or anti-double-stranded DNA (dsDNA) autoantibodies.
Hartley, Louise +17 more
core +1 more source
Objective Ambulatory care–sensitive conditions (ACSCs) serve as indicators of access, quality, and performance of the health system. This study aimed to determine rheumatoid arthritis (RA)‐specific ACSCs for use in the evaluation of care system access and quality.
Kara Irwin +7 more
wiley +1 more source
Prognostic values of sera IL-6/IL-10 and high titration of anti-SSA/Ro and anti-SSB/La autoantibodies in female patients with connective tissue diseases [PDF]
Aim: The high levels of anti-SSA/Ro and anti-SSB/La autoantibodies are closely associated with a group of diseases related to connective tissues, also known as connective tissue diseases (CTD).
Nor Effa S. Zulkafli +5 more
doaj +1 more source
Ets1, a Guardian of T Follicular Helper Cell Differentiation and SLE Development
E26 transformation-specific-1 (Ets1) is a member of the Ets family of transcription factors and plays important functions in the development, proliferation, and survival of immune cells.
IM, SIN HYEOG
core
Objective To assess the validity of the Patient‐Reported Outcomes Measurement Information System (PROMIS) Pediatric measures in patients with chronic nonbacterial osteomyelitis (CNO). Methods Within the longitudinal patient registry of CNO, English‐speaking patients aged 8 years and older self‐reported PROMIS Pediatric measures of fatigue, pain ...
Mary M. Eckert +43 more
wiley +1 more source

